News related to Buminate 25% (Albumin) and/or conditions it is approved for
More LEADER: Liraglutide Delays Progression of Renal Events
Source: Medscape Diabetes & Endocrinology Headlines [2016.09.20]
Nephropathy results from the LEADER trial show that liraglutide reduces renal events by 22% compared with placebo, mainly driven by reduction in new-onset macroalbuminuria.
Medscape Medical News
Overall prevalence of diabetic kidney disease does not change significantly in U.S.
Source: Urology / Nephrology News From Medical News Today [2016.08.12]
Among U.S. adults with diabetes from 1988 to 2014, the overall prevalence of diabetic kidney disease did not change significantly, while the prevalence of albuminuria declined and the prevalence of...
Diabetic Nephropathy - Early intervention is the key
Source: The Doctors Lounge - Nephrology
Dr. Riham explains how annual screening for microalbuminuria in diabetic patients will allow early identification of nephropathy.